Private Placement

An AI procurement firm has joined the council that sets government purchasing standards. Can it solve bureaucracy or will it create new digital gatekeepers?

JETSET Pilates makes its New Mexico debut with a new studio in Albuquerque, offering a modern, full-body workout experience set to a DJ-curated soundtrack.

The largest-ever study on school phone bans confirms huge drops in phone use and improved student well-being, but the impact on test scores is more complex.

After a 'divine' tasting and a major award, Boston's GALY is scaling its tank-grown cocoa and cotton, promising a radical shift in global supply chains.

With a novel 'NewCo' model and key partnerships, Banyan BioInnovations aims to de-risk and accelerate clinical-stage drugs past the funding valley of death.

Central Florida's first new community bank in a decade, Portrait Bank, combines a powerhouse board with AI tech to challenge the region's financial giants.

A new report reveals a dramatic shift in Alzheimer's drug development, with 75% of trials now targeting pathways beyond amyloid for a new age of treatment.

Diagnostic leader Bracco enters the cell therapy market with BubbleGen, a novel microbubble tech that promises to streamline complex manufacturing.

A biotech firm is making waves with a non-viral, redosable gene delivery system showing promise for DMD and hemophilia, challenging the industry's reliance on viruses.

A $33M C-PACE deal for a Deepak Chopra-affiliated resort shows how innovative financing is reshaping real estate development in a tight market.

A new $50M fund unites venture capital with Canada's top cancer charities, aiming to fast-track lab discoveries into life-saving patient treatments.

With new strategic financing and powerhouse board appointments, 4D Path is accelerating its novel AI platform that predicts cancer treatment success from a single slide.

A new firm will underwrite a $400M fund, signaling a shift in patent finance toward specialized expertise and empowering small inventors.

Promising data for its lead drug budoprutug has Climb Bio on a path to potentially redefine treatment for a range of debilitating autoimmune diseases.

Giyani Metals' high-purity manganese meets quality standards from US tech leader C4V, a crucial step in building a non-Chinese battery supply chain.

Enlight Renewable Energy posts strong Q1 results, with underlying profits surging 76% despite a misleading net income dip, and reaffirms its 2026 outlook.

neurocare's TMS device approval marks a major shift in the Kingdom's approach to depression, prioritizing non-invasive, tech-driven solutions.

The clean energy vehicle company is assembling a top-tier team to develop hydrogen-powered drones, aiming for a slice of the $182 billion UGV market.

Beyond its first blockbuster, CRISPR Therapeutics reveals a deep pipeline for autoimmune and liver diseases, backed by a strong Q1 balance sheet.

The cloud storage firm topped Q1 estimates and turned a non-GAAP profit, crediting a surge in AI clients drawn to its low-cost, high-performance data platform.